Ophthalmology Update - Cleveland Clinic

e d U c a t i O n a n d t r a i n i n g
Continuing Medical Education
Continued from page 49
Innovations in Inflammatory Ocular Diseases
Saturday, October 14, 2006
7:30 a.m. to 4:00 p.m.
Course director:
Careen Y. Lowder, M.D., Ph.D.
Uveitis Department
Cleveland Clinic Cole Eye Institute
Cole Eye Institute Faculty:
Peter K. Kaiser, M.D.
Vitreoretinal Surgery Department
Cleveland Clinic Cole Eye Institute
Victor L. Perez, M.D.
Cornea and Uveitis Departments
Cleveland Clinic Cole Eye Institute
Guest Faculty:
Glenn Jaffe, M.D.
Professor, Department of Ophthalmology
Duke University
Durham, NC
Eric Suhler, M.D.
Assistant Professor, Casey Eye Institute
Oregon Health & Science University
Eugene, OR
Howard Tessler, M.D.
Professor, Illinois Eye and Ear Infirmary
Chicago, IL
Scott Whitcup, M.D.
Vice President
Allergan
Irvine, CA
description/Objectives: This course will review the latest treatment
modalities in uveitis including the intravitreal delivery systems for
long-acting and short-acting steroids and the various anti-tumor
necrosis factor alpha. We will compare these new treatments to the
currently accepted systemic immunosuppresssion regimens with
steroids and nonsteroidal immunosuppessive therapy. Cole Eye
Institute experience will be discussed.
At the conclusion of this course, participants should be able to:
1. Describe the use of nonspecific drugs, including immunosuppressive
therapy.
2. Describe current clinical trials in ocular inflammatory diseases.
3. Identify newer therapies for noninfectious posterior
uveitis syndromes.
4. Evaluate and determine which patients will benefit from the
various treatment modalities.
Innovations in Glaucoma
Saturday, December 9, 2006
7:30 a.m. to 4:00 p.m.
Course directors:
Scott D. Smith, M.D., M.P.H.
Edward J. Rockwood, M.D.
Glaucoma Department
Cleveland Clinic Cole Eye Institute
Guest Faculty:
George Baerveldt, MBCHB
Chairman and Professor
Department of Ophthalmology
University of California Irvine Medical Center
Irvine, CA
Reay H. Brown, M.D.
Northside Hospital
Atlanta, GA
description/Objectives: This is an update of diagnostic and surgical
innovations and a new look at old techniques for the management of
glaucoma. There will be didactic lectures, case presentations and
question-and-answer sessions.
At the conclusion of this course, participants should be able to:
1. Identify the role of optic disc imaging in the management of
ocular hypertension and glaucoma.
2. Review a comparison of ultrasound biomicroscopy and OCT
anterior segment imaging for the diagnosis and management of
narrow angles and angle-closure glaucoma.
3. Discuss surgical variations and why glaucoma surgery can be
difficult to simplify and improve.
4. Evaluate outcomes analyses and how they can lead to improved
surgical outcomes in glaucoma.
5. Identify the possible future role of the Eyepass glaucoma device.
6. Identify the role of cataract extraction in the management of
angle-closure glaucoma.
7. Understand the role of the trabectome in the surgical management
of glaucoma.
8. Identify the latest glaucoma implant innovations.
0 // O p h t h a l m O l O g y U p d a t e s p e c i a l e d i t i O n 2 0 0 6